FFP-104
FFP-104 is a humanized IgG4 monoclonal antibody inhibitor targeting TNFRSF5/CD40. VX70 can be used for chronic autoimmune liver diseases research, such as primary biliary cholangitis (PBC) [1].
Product Specifications
CAS Number
[2378693-56-0]
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Khanna A, et al. Novel strategies and therapeutic options for the management of primary biliary cholangitis[J]. Therapeutic Advances in Gastroenterology, 2017, 10 (10) : 791-803.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF5/CD40
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
